中国药学(英文版)
中國藥學(英文版)
중국약학(영문판)
JOURNAL OF CHINESE PHARMACEUTICAL SCIENCES
2007年
2期
105-111
,共7页
梁公文%吕万良%吴瑨威%赵继会%李婷%张宇腾%张华%王坚成%张烜%张强
樑公文%呂萬良%吳瑨威%趙繼會%李婷%張宇騰%張華%王堅成%張烜%張彊
량공문%려만량%오진위%조계회%리정%장우등%장화%왕견성%장훤%장강
长春新碱抗耐药性隐形脂质体%高效液相色谱法%药动学
長春新堿抗耐藥性隱形脂質體%高效液相色譜法%藥動學
장춘신감항내약성은형지질체%고효액상색보법%약동학
Stealthy liposomal vincristine plus quinacrine%HPLC%Pharmacokinetics
目的 构建长春新碱抗耐药性隐形脂质体,并考察其在大鼠体内的药动学.方法 采用硫酸铵梯度法制备长春新碱抗耐药性隐形脂质体;将Spmgue桪awley大鼠分成两组,分别尾静脉注射长春新碱抗耐药性隐形脂质体和游离药,用高效液相二极管阵列色谱法和高效液相荧光色谱法分别测定血浆中长春新碱和奎纳克林的浓度,通过与游离药组比较,评价长春新碱抗耐药性隐形脂质组的药动学特点.结果 长春新碱抗耐药性隐形脂质体的粒径为135.9±7.1nm,其中,长春新碱的包封率大于90%,奎纳克林的包封率大于85%;大鼠尾静脉注射长春新碱抗耐药性隐形脂质体后,与游离药组相比,长春新碱和奎纳克林的血液滞留时间明显增长,并且两者平均血药浓度都明显提高.在长春新碱抗耐药性隐形脂质体组中,长春新碱和奎纳克林的Cmax,t1/2和AUC0-24 h都分别高于游离药组的相应值,然而,长春新碱和奎纳克林的C1都明显低于游离药组的值.结论 本研究成功构建了具有高包封率的长春新碱抗耐药性隐形脂质体.抗耐药性隐形脂质体明显延了长春新碱和奎纳克林在血液中的循环时间并提高了二者血浆中平均血药浓度.
目的 構建長春新堿抗耐藥性隱形脂質體,併攷察其在大鼠體內的藥動學.方法 採用硫痠銨梯度法製備長春新堿抗耐藥性隱形脂質體;將Spmgue桪awley大鼠分成兩組,分彆尾靜脈註射長春新堿抗耐藥性隱形脂質體和遊離藥,用高效液相二極管陣列色譜法和高效液相熒光色譜法分彆測定血漿中長春新堿和奎納剋林的濃度,通過與遊離藥組比較,評價長春新堿抗耐藥性隱形脂質組的藥動學特點.結果 長春新堿抗耐藥性隱形脂質體的粒徑為135.9±7.1nm,其中,長春新堿的包封率大于90%,奎納剋林的包封率大于85%;大鼠尾靜脈註射長春新堿抗耐藥性隱形脂質體後,與遊離藥組相比,長春新堿和奎納剋林的血液滯留時間明顯增長,併且兩者平均血藥濃度都明顯提高.在長春新堿抗耐藥性隱形脂質體組中,長春新堿和奎納剋林的Cmax,t1/2和AUC0-24 h都分彆高于遊離藥組的相應值,然而,長春新堿和奎納剋林的C1都明顯低于遊離藥組的值.結論 本研究成功構建瞭具有高包封率的長春新堿抗耐藥性隱形脂質體.抗耐藥性隱形脂質體明顯延瞭長春新堿和奎納剋林在血液中的循環時間併提高瞭二者血漿中平均血藥濃度.
목적 구건장춘신감항내약성은형지질체,병고찰기재대서체내적약동학.방법 채용류산안제도법제비장춘신감항내약성은형지질체;장Spmgue심awley대서분성량조,분별미정맥주사장춘신감항내약성은형지질체화유리약,용고효액상이겁관진렬색보법화고효액상형광색보법분별측정혈장중장춘신감화규납극림적농도,통과여유리약조비교,평개장춘신감항내약성은형지질조적약동학특점.결과 장춘신감항내약성은형지질체적립경위135.9±7.1nm,기중,장춘신감적포봉솔대우90%,규납극림적포봉솔대우85%;대서미정맥주사장춘신감항내약성은형지질체후,여유리약조상비,장춘신감화규납극림적혈액체류시간명현증장,병차량자평균혈약농도도명현제고.재장춘신감항내약성은형지질체조중,장춘신감화규납극림적Cmax,t1/2화AUC0-24 h도분별고우유리약조적상응치,연이,장춘신감화규납극림적C1도명현저우유리약조적치.결론 본연구성공구건료구유고포봉솔적장춘신감항내약성은형지질체.항내약성은형지질체명현연료장춘신감화규납극림재혈액중적순배시간병제고료이자혈장중평균혈약농도.
Aim The objectives of the present study were to prepare stealthy vincristine plus quinacrine liposomes and evaluate the pharmacokinetics in Sprague-Dawley rats. Methods Anti-resistant stealthy liposomes were prepared by incorporating vincristine with quinacrine together using the ammonium sulfate gradient loading procedure. For the pharrnacokinetic study, Sprague-Dawley rats were divided into two groups: each rat in the Group I was administered intravenously via tail vein as stealthy liposomal vincristine plus quinacrine, and the Group Ⅱ similarly given as a mixture solution of free vincristine plus free quinacrine. The concentrations of vincristine and quinacrine in plasma were measured by HPLC with diode array detection and fluorescence detection, respectively. Results The mean particle size of stealthy liposomes was 135.9±7.1 nm and the encapsulation efficiencies of stealthy liposomes were>90% for vincristine, and>85% for quinacrine, respectively. Administered as the stealthy vincristine plus quinacrine liposomes, the plasma exposures of both vincristine and quinacrine were significantly extended, and the mean concentrations of both vincristine and quinacrine were significantly higher compared to those given as the mixture solution of free vincristine plus free quinacrine. The C,max,t1/2 AUC0-24 h values of vincristine for stealthy liposomal group were significantly increased, but the total clearance C1 values decreased, as compared to those of free drug group, respectively. Similarly, the Cmax,t1/2 and AUC0-24 h values of quinacrine for the stealthy liposomal group were significantly increased, but the total clearance C1 values decreased, as compared to those of free quinacrine. Conclusion The anti-resistant stealthy liposomes are successfully prepared by incorporating vincristine with quinacrine, and the liposomes extend significantly the duration in blood circulation and improve evidently the plasma concentrations of both vincristine and quinacrine.